MindMed Reports Second Quarter 2022 Financial Results and Business Highlights ...Middle East

PR Newswire - News
MindMed Reports Second Quarter 2022 Financial Results and Business Highlights
– Phase 2b dose-optimization trial in patients with General Anxiety Disorder underway with first patient dosing expected in Q3 2022 – – Advanced IND-enabling studies for MM-402 with the Phase 1 investigator-initiated pharmacokinetic/pharmacodynamic trial on track to initiate in Q3 2022 –...

Hence then, the article about mindmed reports second quarter 2022 financial results and business highlights was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( MindMed Reports Second Quarter 2022 Financial Results and Business Highlights )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News